{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "country": "United States",
      "city": "Fajardo",
      "address_1": "G12 Calle Principal",
      "reason_for_recall": "Marketed Without an Approved NDA/ANDA: FDA lab results found undeclared API Fluoxetine in this dietary supplement.",
      "address_2": "Baralt Ste #3",
      "product_quantity": "1,146 bottles",
      "code_info": "Lot #: 052012, Exp 10/2015",
      "center_classification_date": "20140425",
      "distribution_pattern": "Nationwide and Puerto Rico",
      "state": "PR",
      "product_description": "Adipotrim XT, New Powerful Formula, 30 rapid release capsules per bottle, Dietary Supplement, www.adipotrim.com.",
      "report_date": "20140507",
      "classification": "Class I",
      "openfda": {},
      "recalling_firm": "Deseo Rebajar",
      "recall_number": "D-1277-2014",
      "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit",
      "product_type": "Drugs",
      "event_id": "66817",
      "termination_date": "20170503",
      "more_code_info": "",
      "recall_initiation_date": "20131107",
      "postal_code": "00738-3774",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "status": "Terminated"
    }
  ]
}